SARS-CoV-2感染住院患者的维生素D状态
这项回顾性病例对照研究纳入216例COVID-19住院患者与197名人群对照,比较血清25OHD水平并分析其与疾病严重程度的关系。患者25OHD均值为13.8±7.2 ng/mL,低于对照的20.9±7.4 ng/mL(P<.0001),维生素D缺乏率分别为82.2%与47.2%(P<.0001)。未发现维生素D缺乏与COVID-19严重程度复合终点或其各组成部分之间存在因果关系。
要点
- 住院COVID-19患者25OHD水平显著低于人群对照,缺乏率更高。
- 25OHD与铁蛋白(P=.013)、D-二聚体(P=.027)呈负相关。
- 未发现维生素D缺乏与疾病严重程度相关的因果证据。
核心结论
- 住院COVID-19患者25OHD水平低于人群对照且缺乏率更高。
- 未发现维生素D浓度或缺乏与疾病严重程度之间存在关系。
研究设计与样本
- 回顾性病例对照研究,纳入216例COVID-19患者和197名人群对照。
- 两组均测定血清25OHD水平,并评估其与COVID-19严重程度的关联。
- 216例患者中19例正在补充维生素D,被单独分析。
主要发现
- 患者25OHD均值13.8±7.2 ng/mL,对照20.9±7.4 ng/mL(P<.0001)。
- 维生素D缺乏在病例中占82.2%,对照中占47.2%(P<.0001)。
- 男性25OHD值低于女性。
- 25OHD与血清铁蛋白(P=.013)和D-二聚体(P=.027)呈负相关。
- 维生素D缺乏患者高血压和心血管疾病患病率更高、铁蛋白和肌钙蛋白升高、住院时间更长。
关键数值与推荐
- 维生素D缺乏与COVID-19严重程度复合终点及其各组成部分均无因果关系。
临床怎么用
- 住院COVID-19患者应关注维生素D状态评估,但不应以改善维生素D为由推断可降低疾病严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of vitamin D status in COVID-19 patients is a matter of debate. OBJECTIVES: To assess serum 25-hydroxyvitamin D (25OHD) levels in hospitalized patients with COVID-19 and to analyze the possible influence of vitamin D status on disease severity. METHODS: Retrospective case-control study of 216 COVID-19 patients and 197 population-based controls. Serum 25OHD levels were measured in both groups. The association of serum 25OHD levels with COVID-19 severity (admission to the intensive care unit, requirements for mechanical ventilation, or mortality) was also evaluated. RESULTS: Of the 216 patients, 19 were on vitamin D supplements and were analyzed separately. In COVID-19 patients, mean ± standard deviation 25OHD levels were 13.8 ± 7.2 ng/mL, compared with 20.9 ± 7.4 ng/mL in controls (P < .0001). 25OHD values were lower in men than in women. Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of population-based controls (P < .0001). 25OHD inversely correlates with serum ferritin (P = .013) and D-dimer levels (P = .027). Vitamin D-deficient COVID-19 patients had a greater prevalence of hypertension and cardiovascular diseases, raised serum ferritin and troponin levels, as well as a longer length of hospital stay than those with serum 25OHD levels ≥20 ng/mL. No causal relationship was found between vitamin D deficiency and COVID-19 severity as a combined endpoint or as its separate components. CONCLUSIONS: 25OHD levels are lower in hospitalized COVID-19 patients than in population-based controls and these patients had a higher prevalence of deficiency. We did not find any relationship between vitamin D concentrations or vitamin deficiency and the severity of the disease.
引用
- Hernández JL, Nan D, Fernandez-Ayala M, et al. Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection. J Clin Endocrinol Metab. 2021. PMID: 33159440. doi:10.1210/clinem/dgaa733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。